CLASS II Device recall · Reported 1 Feb 2017 · FDA Enforcement Report

Sekisui Diagnostics Ammonia L3K¿ Assay recalled

Sekisui Diagnostics P.E.I is recalling Sekisui Diagnostics Ammonia L3K¿ Assay, distributed in 11 states. The recall was initiated on 29 Nov 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesCatalog Number: 293-80-91; Lot Numbers: 48737, 48962, 49087, 49220, 49258 and Catalog Numbers: 293-10; Lot Numbers: 48967, 49330, 49331, 49515
Quantity recalled774 Liters bulk and 565 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1078-2017
FDA event ID
75818
Recalling firm
Sekisui Diagnostics P.E.I, Charlottetown, N/A
Classification
Class II
Status
Terminated
Recall initiated
29 Nov 2016
FDA classified
23 Jan 2017
Reported
1 Feb 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

29 Nov 2016Recall initiated by company
23 Jan 2017Classified by FDA+55 days
1 Feb 2017Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Certain lots are showing an atypical decrease in optical density (OD) over time, which may result in an impact to performance at the high end of the linear range.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Sekisui Diagnostics Ammonia L3K¿ Assay; Catalog Number: 293-80-91 and 293-10 For the IN VITRO quantitative measurement of ammonia concentration in plasma

Where it was distributed

Worldwide Distribution - US including DE, KS, FL, TX, CA, MI, TN, MA, ID, NJ, RI, IL and Internationally to Austria, Mexico, Canada, India, South Korea, China, Spain, South Korea, and Sri Lanka

CaliforniaFloridaIdahoIllinoisKansasMassachusettsMichiganNew JerseyRhode IslandTennesseeTexas

Questions about this recall

Why was it recalled?

Certain lots are showing an atypical decrease in optical density (OD) over time, which may result in an impact to performance at the high end of the linear range.

Which lots are affected?

Catalog Number: 293-80-91; Lot Numbers: 48737, 48962, 49087, 49220, 49258 and Catalog Numbers: 293-10; Lot Numbers: 48967, 49330, 49331, 49515

Where was it sold?

Worldwide Distribution - US including DE, KS, FL, TX, CA, MI, TN, MA, ID, NJ, RI, IL and Internationally to Austria, Mexico, Canada, India, South Korea, China, Spain, South Korea, and Sri Lanka

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Sekisui Diagnostics P.E.I

All 2
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IISekure Chemistry Sekisui Diagnostics Acetaminophen L3K recalledSekisui Diagnostics P.E.IPotency & Assay10 states

Other Test Kits & Diagnostics recalls

All 2,656